echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > If you have this disease, will it affect your pregnancy attempt?

    If you have this disease, will it affect your pregnancy attempt?

    • Last Update: 2023-01-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    For medical professionals only



    On the relationship between SLE and pregnancy


     

    Systemic lupus erythematosus (SLE) is an autoimmune inflammatory connective tissue disease
    involving multiple organs in young women.


    The cause of systemic lupus erythematosus is currently unknown
    .
    Possible factors include: genetic predisposition, estrogen, environmental factors
    (ultraviolet light, drugs, smoking, etc.
    ), viral infections, etc
    .


    One

    How is systemic lupus erythematosus (SLE) diagnosed?


    The diagnosis of suspected SLE is recommended using the 2012 International Lupus Research Clinical Collaborative Group (SLICC) or the 2019 EULAR/ACR SLE classification criteria
    .

    EULAR/ACR 2019 SLE classification standard


    Two

    How are peripregnant patients managed?


    1.
    For women of childbearing age with SLE, if the condition is stable for at least 6 months, there is no damage to important organs, and the potentially teratogenic drugs are discontinued to a safe enough time, pregnancy can be considered
    .


    2.
    If you plan to become pregnant, you should consult with rheumatology and immunology and obstetricians and gynecologists before pregnancy and conduct relevant assessments
    .


    3.
    For pregnant SLE patients, SLE disease activity and fetal growth and development should be closely
    monitored.


    4.
    If there are no contraindications, it is recommended to take hydroxychloroquine throughout pregnancy, and if there is disease activity, you can consider the use of hormones and azathioprine to control the disease
    .


    5.
    The use of azathioprine during pregnancy in SLE patients will not cause fetal teratogenicity, and can reduce the risk of disease recurrence and improve fetal outcomes
    .


    6.
    Hydroxychloroquine, hormones, azathioprine, cyclosporine A and tacrolimus can be used to prevent or control SLE recurrence during pregnancy, but mycophenolate mofetil, cyclophosphamide, leflunomide and methotrexate should not be used
    .


    Patients with SLE perigestational capacity is not affected by disease, but there is a risk of poor pregnancy outcome and planned pregnancy
    should be on medical advice.


    How to deal with organ and system involvement in pregnant mothers?

    More guidelines for systemic lupus erythematosus can be found in the Clinical Decision App

    It can also support one-click translation of English guides


    References:

    [1] 2020 Chinese guidelines for the diagnosis and treatment of systemic lupus erythematosus


    ▼▼Click to read the original article to download the App

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.